HomeNewsBusinessStocksBuy Cipla, advises Sushil Kedia

Buy Cipla, advises Sushil Kedia

Sushil Kedia of Dir-Quantitative Strategy, CIMB recommends buying Cipla within the pharma space. "One may see Hindustan Unilever rebounding by 10-15 percent from the current levels," he adds.

December 14, 2013 / 13:15 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Sushil Kedia of Director-Quantitative Strategy, CIMB told CNBC-TV18, "IT have had been sort of a safe space in last one week. However if the focus is about next one week or 10 days then there is nothing much really left in them. I would like to wait for the behaviour next week. If indeed the CNX IT closes lower by 3-4 percent from where it closed then there may be a sell signal."

He further added, "I would like to reserve my opinion, but in terms of defensives on a trading time frame or even in a one-month time frame Hindustan Unilever (HUL) has come off quite a lot. It has not participated in this last 10 percent Nifty upmove. It has started showing technical signs of good rebound coming up from here by 10-15 percent. Even ITC may join in that."

Story continues below Advertisement

"From the pharma pack, the defensive stocks that I am looking to have a buy signal on in the next couple of days is Cipla. Infact from all the list of F&O stocks I don’t find many buying ideas. Different timeframes, different outlook - so, the next 10-15 days there are very few selective stocks that may produce any sustainable rally while next couple of days there should be some small rebound because there has been already a nice large fall," Kedia said.

first published: Dec 14, 2013 01:15 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!